Redx Pharma

Block 33, Mereside, Alderley Park, Macclesfield, SK10 4TG, United Kingdom , London, Greater London
4.6
271 Reviews
Today: Closed now | Tomorrow (Saturday): 10:00 - 19:00
Website View Phone

Description
Quick Information
Support
Photo
Reviews
FAQ

More About Business

Name: Redx Pharma Limited

Business Headquarter: United Kingdom, Cheshire, Macclesfield

Business Category: Biotechnology / Pharmaceutical Research & Development

Blue pages Redx Pharma Limited is a clinical-stage biotechnology company at the forefront of developing novel, small molecule targeted medicines for the treatment of fibrotic disease and cancer. Based at Alderley Park, the UK’s largest single-site life science campus, Redx leverages its world-class expertise in medicinal chemistry and translational science to discover differentiated therapeutics against clinically validated targets.

The blue pages Redx Pharma Limited value proposition is built on a "lead-fast" discovery engine that has successfully progressed six molecules into clinical development. Our current primary focus is the "ROCK" (Rho-associated protein kinase) portfolio, featuring zelasudil, a selective ROCK2 inhibitor for interstitial lung diseases, and RXC008, a first-in-class GI-restricted inhibitor for Crohn's disease. Our mission is to improve patient lives by tackling some of the most challenging fibrotic conditions where significant unmet medical needs exist. Beyond its wholly-owned pipeline, Redx maintains high-value strategic partnerships with global leaders like AstraZeneca and Jazz Pharmaceuticals, further validating its scientific platform and providing a sustainable pathway for late-stage commercialization.

Business Helpdesk Number: +44 (0)1625 469900

Founder Name: Lisa Anson (Chief Executive Officer)

Founded Date: 2010-09-07

Phone Number: +44 (0)1625 469900

Email Address: info@redxpharma.com / redxpharma@fticonsulting.com (Media)

Website URL: https://www.redxpharma.com

Physical Address: Block 33, Mereside, Alderley Park, Macclesfield, SK10 4TG, United Kingdom

Landmark: Near the Alderley Park Conference Centre and AstraZeneca campus

Service or Products: Clinical-stage drug development, Fibrosis therapeutics (RXC008, Zelasudil), Oncology discovery programs (Porcupine inhibitors), Small molecule medicinal chemistry, Translational science consulting.

Amenities: State-of-the-art laboratory facilities, Collaborative R&D spaces, Technical clinical trial support, Investor reporting hub.

Accepted Payment Methods: Institutional Funding, Venture Capital, Milestone-based partnering payments.

Languages Supported: English.

Specialization: ROCK1/2 Inhibitors, Fibrostenotic Crohn’s Disease Research, Idiopathic Pulmonary Fibrosis (IPF) Trials, Porcupine Inhibition in Wnt-ligand driven cancers.

Certifications: MHRA Compliant, FDA Fast Track Designations (RXC008), Orphan Drug Designations.

Social Media Links:

LinkedIn: https://www.linkedin.com/company/redx-pharma

Business Registration Number: 07368089

Brand Association Name: Redx, Alderley Park Biotech.

Working Hours: Monday–Friday: 09:00 AM – 05:30 PM

Additional Information:

Year Founded: 2010

Brands: Redx, RXC008, Zelasudil.

Number of Employees: 100+

Associations: BioIndustry Association (BIA), ABPI, Alderley Park Life Science Cluster.

FAQs

What is the "blue pages" status for Redx Pharma?
This is the verified March 2026 entry, confirming the company's private status and its recent 2026 FDA Fast Track and clinical hold updates.

What does "GI-restricted" mean for RXC008?
It means the drug is designed to act specifically in the gastrointestinal tract, minimizing systemic absorption and reducing side effects throughout the rest of the body.

Is Redx still developing cancer treatments?
Yes. While fibrosis is the primary focus, Redx continues to advance its oncology assets, including porcupine inhibitors for GI-related tumors, often in partnership with other pharma companies.

How can I invest in Redx if it is no longer on AIM?
As a private company, Redx is no longer traded on public exchanges. Institutional and private investors typically participate through venture capital rounds or private placements.

Where are the clinical trials taking place?
Redx conducts global clinical trials across the UK, Europe, and the US, with recent focus on US-based Phase 2 trials for its ROCK inhibitor portfolio.

2026 Corporate Status & Operational Update: As of March 21, 2026, Redx Pharma is operating as a private limited company following its strategic delisting from the London Stock Exchange (AIM) in May 2024. The company recently achieved a major regulatory milestone on March 10, 2026, when its lead candidate, RXC008, received US FDA Fast Track Designation for the treatment of fibrostenotic Crohn’s disease. Additionally, the FDA lifted a partial clinical hold on its ROCK2 inhibitor, zelasudil (RXC007), in January 2026, allowing the company to progress its Phase 2a idiopathic pulmonary fibrosis (IPF) programs with full momentum.

Social Media

Quick Information

Business summaryblue pages Redx Pharma Limited is a clinical-stage biotech developing breakthrough small molecule treatments for Crohn’s disease and pulmonary fibrosis.
Year of Establishment2010
AssociationsBioIndustry Association (BIA), ABPI, Alderley Park Life Science Cluster.

Support

Contact the official Redx Pharma Support Number for fast, reliable assistance in the Business Services industry. The Redx Pharma customer care team is available to handle inquiries. You can also access the Redx Pharma official website at www.redxpharma.com for complete service details. For written queries, use the Redx Pharma support email. Located at Block 33, Mereside, Alderley Park, Macclesfield, SK10 4TG, United Kingdom, London, Greater London United Kingdom.

Reach the Redx Pharma contact number to connect with verified experts in the Business Services sector. The Redx Pharma helpline offers quick resolutions and trusted guidance. You can also contact the Redx Pharma support team through official Redx Pharma email for professional assistance.